The year ahead in digital health and life sciences: the pharmaphorum podcast
In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe). Tune […]
JP Morgan
Digital health innovation in 2022: Anticipating healthcare trends ahead of the J.P. Morgan week
We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation in healthcare, including the potential of digital […]
Navigating the life science and healthcare funding landscape [Sponsored]
Which capital funding options fit your healthcare or life science business?
Covid-19 was a lightning rod for life science deals last year. What investment trends are taking shape in 2021? [Sponsored]
Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with […]
A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay
Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be […]
J.P. Morgan’s life sciences outlook for 2021 [Sponsored]
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to […]
Haven: The strategy that didn’t fix healthcare
John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix […]
Gene editing: beyond the hype
Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy […]
A Haven No More
Haven was a high-profile effort whereby three industry titans–Amazon, Berkshire Hathaway and JP Morgan–created a joint venture with the hope of lower costs and improving […]
Return to work: a sector-by-sector look at the plans of England’s major employers
Companies can return to work from 1 August, but many employers are making their own plans Companies ready to defy Boris Johnson’s planned return to […]
